Global Gastroparesis Drugs Competitive Landscape Professional Research Report 2024

Global Gastroparesis Drugs Competitive Landscape Professional Research Report 2024



Research Summary

Gastroparesis drugs are medications designed to manage the symptoms and complications of gastroparesis, a condition characterized by delayed emptying of the stomach, leading to symptoms such as nausea, vomiting, abdominal pain, and a feeling of fullness. The primary goal of these drugs is to regulate and improve stomach motility, helping to move food through the digestive system more efficiently. Prokinetic agents, such as metoclopramide and domperidone, are commonly prescribed to stimulate stomach contractions and facilitate gastric emptying. Additionally, antiemetic drugs may be prescribed to alleviate nausea and vomiting associated with gastroparesis. While there is no cure for gastroparesis, these medications aim to provide symptomatic relief and improve the overall quality of life for individuals affected by this gastrointestinal disorder. Treatment plans may also include dietary modifications, lifestyle changes, and in severe cases, surgical interventions to manage the condition effectively.

According to DIResearch's in-depth investigation and research, the global Gastroparesis Drugs market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Hanmi Pharm, Kyowa Kirin Pharmaceuticals, Ani Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Gastroparesis Drugs. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastroparesis Drugs market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastroparesis Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastroparesis Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gastroparesis Drugs Include:

Sumitomo

Cadila Pharmaceuticals

Sanofi

Teva

Johnson & Johnson

Pfizer

Hanmi Pharm

Kyowa Kirin Pharmaceuticals

Ani Pharmaceuticals

Gastroparesis Drugs Product Segment Include:

Prokinetic Agents

Antiemetic Agents

Others

Gastroparesis Drugs Product Application Include:

Diabetic Gastroparesis

Idiopathic Gastroparesis

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Gastroparesis Drugs Industry PESTEL Analysis

Chapter 3: Global Gastroparesis Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Gastroparesis Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Gastroparesis Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Gastroparesis Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Gastroparesis Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Gastroparesis Drugs Market Overview
1.1 Product Definition and Statistical Scope
1.2 Gastroparesis Drugs Product by Type
1.2.1 Global Gastroparesis Drugs Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Gastroparesis Drugs Product by Application
1.3.1 Global Gastroparesis Drugs Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Global Gastroparesis Drugs Market Revenue and Sales Analysis
1.4.1 Global Gastroparesis Drugs Market Size Analysis (2019-2030)
1.4.2 Global Gastroparesis Drugs Market Sales Analysis (2019-2030)
1.4.3 Global Gastroparesis Drugs Market Sales Price Trend Analysis (2019-2030)
1.5 Gastroparesis Drugs Market Development Status and Trends
1.5.1 Gastroparesis Drugs Industry Development Status Analysis
1.5.2 Gastroparesis Drugs Industry Development Trends Analysis
2 Gastroparesis Drugs Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Gastroparesis Drugs Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Gastroparesis Drugs Market Analysis by Regions
4.1 Gastroparesis Drugs Overall Market: 2023 VS 2024 VS 2030
4.2 Global Gastroparesis Drugs Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Gastroparesis Drugs Revenue and Market Share by Region (2019-2024)
4.2.2 Global Gastroparesis Drugs Revenue Forecast by Region (2025-2030)
4.3 Global Gastroparesis Drugs Sales and Forecast Analysis (2019-2030)
4.3.1 Global Gastroparesis Drugs Sales and Market Share by Region (2019-2024)
4.3.2 Global Gastroparesis Drugs Sales Forecast by Region (2025-2030)
4.4 Global Gastroparesis Drugs Sales Price Trend Analysis (2019-2030)
5 Global Gastroparesis Drugs Market Size by Type and Application
5.1 Global Gastroparesis Drugs Market Size by Type
5.1.1 Global Gastroparesis Drugs Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Gastroparesis Drugs Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Gastroparesis Drugs Market Size by Application
5.2.1 Global Gastroparesis Drugs Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Gastroparesis Drugs Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Gastroparesis Drugs Market Size by Type
6.3.1 North America Gastroparesis Drugs Sales by Type (2019-2030)
6.3.2 North America Gastroparesis Drugs Revenue by Type (2019-2030)
6.4 North America Gastroparesis Drugs Market Size by Application
6.4.1 North America Gastroparesis Drugs Sales by Application (2019-2030)
6.4.2 North America Gastroparesis Drugs Revenue by Application (2019-2030)
6.5 North America Gastroparesis Drugs Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Gastroparesis Drugs Market Size by Type
7.3.1 Europe Gastroparesis Drugs Sales by Type (2019-2030)
7.3.2 Europe Gastroparesis Drugs Revenue by Type (2019-2030)
7.4 Europe Gastroparesis Drugs Market Size by Application
7.4.1 Europe Gastroparesis Drugs Sales by Application (2019-2030)
7.4.2  Europe Gastroparesis Drugs Revenue by Application (2019-2030)
7.5 Europe Gastroparesis Drugs Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Gastroparesis Drugs Market Size by Type
8.3.1 China Gastroparesis Drugs Sales by Type (2019-2030)
8.3.2 China Gastroparesis Drugs Revenue by Type (2019-2030)
8.4 China Gastroparesis Drugs Market Size by Application
8.4.1 China Gastroparesis Drugs Sales by Application (2019-2030)
8.4.2 China Gastroparesis Drugs Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Gastroparesis Drugs Market Size by Type
9.3.1 APAC (excl. China) Gastroparesis Drugs Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Gastroparesis Drugs Revenue by Type (2019-2030)
9.4 APAC (excl. China) Gastroparesis Drugs Market Size by Application
9.4.1 APAC (excl. China) Gastroparesis Drugs Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Gastroparesis Drugs Revenue by Application (2019-2030)
9.5 APAC (excl. China) Gastroparesis Drugs Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Gastroparesis Drugs Market Size by Type
10.3.1 Latin America Gastroparesis Drugs Sales by Type (2019-2030)
10.3.2 Latin America Gastroparesis Drugs Revenue by Type (2019-2030)
10.4 Latin America Gastroparesis Drugs Market Size by Application
10.4.1 Latin America Gastroparesis Drugs Sales by Application (2019-2030)
10.4.2 Latin America Gastroparesis Drugs Revenue by Application (2019-2030)
10.5 Latin America Gastroparesis Drugs Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Gastroparesis Drugs Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Gastroparesis Drugs Market Size by Type
11.3.1 Middle East & Africa Gastroparesis Drugs Sales by Type (2019-2030)
11.3.2 Middle East & Africa Gastroparesis Drugs Revenue by Type (2019-2030)
11.4 Middle East & Africa Gastroparesis Drugs Market Size by Application
11.4.1 Middle East & Africa Gastroparesis Drugs Sales by Application (2019-2030)
11.4.2 Middle East & Africa Gastroparesis Drugs Revenue by Application (2019-2030)
11.5 Middle East & Africa Gastroparesis Drugs Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Gastroparesis Drugs Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Gastroparesis Drugs Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Gastroparesis Drugs Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Gastroparesis Drugs Average Sales Price by Manufacturers (2020-2024)
12.2 Gastroparesis Drugs Competitive Landscape Analysis and Market Dynamic
12.2.1 Gastroparesis Drugs Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Sumitomo
13.1.1 Sumitomo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Sumitomo Gastroparesis Drugs Product Portfolio
13.1.3 Sumitomo Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 Cadila Pharmaceuticals
13.2.1 Cadila Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio
13.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Sanofi
13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Sanofi Gastroparesis Drugs Product Portfolio
13.3.3 Sanofi Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 Teva
13.4.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Teva Gastroparesis Drugs Product Portfolio
13.4.3 Teva Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Johnson & Johnson Gastroparesis Drugs Product Portfolio
13.5.3 Johnson & Johnson Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Pfizer
13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Pfizer Gastroparesis Drugs Product Portfolio
13.6.3 Pfizer Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 Hanmi Pharm
13.7.1 Hanmi Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Hanmi Pharm Gastroparesis Drugs Product Portfolio
13.7.3 Hanmi Pharm Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.8 Kyowa Kirin Pharmaceuticals
13.8.1 Kyowa Kirin Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio
13.8.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.9 Ani Pharmaceuticals
13.9.1 Ani Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio
13.9.3 Ani Pharmaceuticals Gastroparesis Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Gastroparesis Drugs Industry Chain Analysis
14.2 Gastroparesis Drugs Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Gastroparesis Drugs Typical Downstream Customers
14.4 Gastroparesis Drugs Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings